Jasper Therapeutics, Inc.
JSPR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001788028
No open-market purchases or sales by Jasper Therapeutics, Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $5.05M in total; no superinvestor holds it.
Other share classesJSPRW
Q4 2021 vs. Q3 2021
How the institutions holding Jasper Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 9 | 25 | +16 |
| Shares | 10.3M | 20.9M | +10.6M (+103.1%) |
| Value | $101.4M | $160.7M | +$59.3M (+58.4%) |
New holders (19)
Institutions that held Jasper Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 5,852,982 | $45.9M | 21.14% |
| Velan Capital Investment Management LP | 3,219,036 | $22.9M | 19.17% |
| Kingdon Capital Management, L.L.C. | 540,000 | $4.24M | 0.63% |
| Vanguard Group Inc | 483,503 | $3.79M | 0.00% |
| Grace Capital | 218,110 | $1.71M | 1.02% |
| BlackRock Inc. | 169,493 | $1.33M | 0.00% |
| Geode Capital Management, LLC | 117,050 | $918.0K | 0.00% |
| Vahanian & Associates Financial Planning Inc. | 25,000 | $196.0K | 0.16% |
| Virtu Financial LLC | 20,743 | $163.0K | 0.02% |
| Northern Trust Corp | 20,289 | $159.0K | 0.00% |
| Millennium Management LLC | 19,922 | $156.0K | 0.00% |
| Goldman Sachs Group Inc | 17,749 | $139.0K | 0.00% |
| Truist Financial Corp | 11,250 | $89.0K | 0.00% |
| Paloma Partners Management Co | 10,141 | $80.0K | 0.00% |
| Penserra Capital Management LLC | 2,727 | $21.0K | 0.00% |
| Simplex Trading, LLC | 700 | $5.00K | 0.00% |
| Wells Fargo & Company | 251 | $2.00K | 0.00% |
| Ionic Capital Management LLC | 100 | $1.00K | 0.00% |
| SkyView Investment Advisors, LLC | 5 | $0 | 0.00% |
Sold out (3)
Institutions that held Jasper Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Jane Street Group, LLC | 26,030 | $267.0K |
| Tudor Investment Corp Et Al | 20,000 | $205.0K |
| Royal Bank of Canada | 201 | $2.00K |